AngioDynamics Reports Fiscal 2023 Third Quarter Financial Results; Revises Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
AngioDynamics (ANGO) Misses Q3 EPS by 2c, Offers Guidance
March 30, 2023 7:05 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q3 EPS of ($0.03), $0.02 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $80.7 million versus the consensus estimate of $83.2 million.
GUIDANCE:
AngioDynamics sees FY2023 EPS of ($0.06)-($0.01), versus the consensus of ($0.01). AngioDynamics sees... More
